Compare FELE & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FELE | APGE |
|---|---|---|
| Founded | 1944 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.7B |
| IPO Year | N/A | 2023 |
| Metric | FELE | APGE |
|---|---|---|
| Price | $99.07 | $82.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $107.00 | $101.89 |
| AVG Volume (30 Days) | 246.3K | ★ 1.0M |
| Earning Date | 02-17-2026 | 03-02-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.07 | N/A |
| Revenue | ★ $2,110,140,000.00 | N/A |
| Revenue This Year | $7.80 | N/A |
| Revenue Next Year | $4.77 | N/A |
| P/E Ratio | $32.45 | ★ N/A |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $78.87 | $26.20 |
| 52 Week High | $108.08 | $80.99 |
| Indicator | FELE | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 70.88 |
| Support Level | $97.88 | $75.02 |
| Resistance Level | $100.94 | $80.24 |
| Average True Range (ATR) | 2.04 | 3.51 |
| MACD | 0.05 | -0.14 |
| Stochastic Oscillator | 59.07 | 79.33 |
Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.